Artery Roadshow Hall Issue VI: Showcasing 29 High-Potential Projects Across Five Key Healthcare Sectors

A review of investment and financing activities in the healthcare sector in 2019 reveals that, against a backdrop of capital market caution, the overall pace of investment slowed and decision-making became more prudent. As the market separated the wheat from the chaff, capital flowed predominantly to high-value projects characterized by robust technology, innovative business models, and substantial market potential within their chosen sectors.

The healthcare sector is replete with high-quality projects, yet these ventures require greater exposure to facilitate connections with capital. Since the launch of its five online roadshow series, each project has successfully connected with an average of six investment institutions, and 80% of the projects have maintained positive engagement with investors. VCBeat Roadshow Hall welcomes more fundraising projects to join our online roadshows, working together to build a platform for investment and financing exchange.

In addition to featuring four high-quality projects, this edition of the VCBeat Roadshow Hall also reviews past initiatives. Spanning five major sectors—pharmaceuticals and medical devices, biotechnology, service innovation, digital innovation, and healthcare facilities—a total of 29 projects compete for prominence. Take a quick look at these top contenders in action.

Corporate Tags:

Internet of Things, Smart Elderly Care, Smart Healthcare

Project Introduction:

Guangdong Zhongke Cihang leverages its proprietary algorithms to provide medical and elderly care institutions with the Ci’antong IoT healthcare solution, an integrated triad of “smart hardware + mobile app + cloud backend.” To date, Ci’antong has accumulated vast amounts of data for healthcare institutions in areas such as intelligent positioning and real-time utilization analysis of medical equipment, as well as location-based monitoring and care for special-needs patients. This data supports the establishment of refined management models and risk control systems, thereby enhancing overall operational efficiency.

Ci’antong’s IoT Hospital Solution has been implemented at renowned Grade 3A hospitals in China, including The First Affiliated Hospital of Sun Yat-sen University, The First Affiliated Hospital of Jinan University, and The Third Affiliated Hospital of Southern Medical University. Meanwhile, Ci’antong’s Smart Care System for IoT-enabled Medical and Elderly Care Institutions is being progressively deployed across nursing homes, elderly care facilities, and psychiatric hospitals in provinces and municipalities nationwide, such as the Pearl River Delta region, Hubei, Shandong, Shanghai, and Ningxia.

Currently holding 21 independent intellectual property rights, all products (software/hardware) are independently developed. The Ci'antong IoT Hospital solution for hospitals (special patient care and asset positioning/energy efficiency) won the Most Potential Award in the finals of the 2019 Smart Healthcare Innovation Competition and the Second Prize in the Guangdong Division.

Financing History: First Round of Financing

Funding Round:Pre-Series A

Financing Amount:RMB 10 million

Use of Funds:Brand Promotion, Technological Upgrading, Channel Expansion

Project Valuation:RMB 100 million

Corporate Tags:

Internet-based Dental Healthcare, Shared Dental Clinics

Project Introduction:

“Book a Dentist” comprises both an online platform and offline clinics. The online platform includes interfaces for doctors, patients, clinics, and operations, forming a complete business and data loop. The offline clinics operate on a shared dental clinic model, which significantly reduces operational costs, improves operational efficiency, and increases return on investment.

Currently, dentists in the industry are dissatisfied with existing practice models, patients are unhappy with their current healthcare experiences, and dental clinics face immense operational pressures under traditional business models. York Dentist offers a fourth business model: “Dentist Independent Practice Platform + Shared Dental Clinics + Patient Oral Health Management.” By assembling a cross-disciplinary team integrating “Internet + Healthcare,” it aims to effectively enhance the quality and efficiency of oral healthcare services.

Financing History:

Angel Round RMB 7 million Individual Investors

Pre-Series A RMB 15 million Zhuhai Happy Century

Pre-A+ Round RMB 8 Million Company Shareholders

Financing Round:Series A

Financing Amount:RMB 30 million

Use of Proceeds:Online Platform Development, Offline Clinic Expansion, Physician Operations System Construction, Patient Health Management System Construction

Project Valuation:RMB 200 million

Enterprise Tags:

Medical Big Data, DRG Cost Control, and Lean Hospital Management

Project Introduction:

ThickLi’s product, DMIAES, leverages medical big data modeling to deeply integrate hospital management operations into information technology infrastructure, creating a closed-loop ecosystem for hospital management applications. Its product portfolio includes the Hospital Supervision and Control Platform, the Hospital Refined Management Platform, and the Physician Recommendation Platform, empowering both data generators and users to harness data for their own benefit and maximize the value of data applications.

DMIAES product clients include government entities and hospitals (government clients comprise Health Commissions and Healthcare Security Administrations; current government adopters include one municipal-level Health Commission, two provincial-level Health Commissions, two National Health Commission projects, and one municipal-level Healthcare Security Administration).

Furthermore, Houli Information introduced disease risk adjustment in 2015. The company holds 11 granted invention patents, has 5 invention patent applications pending, and owns 4 software copyrights. At the 2019 CHIMA National Healthcare Big Data Application Conference, two of its cases were recognized as “Excellent Cases” (out of only nine such awards nationwide).

Financing History:

2015 Angel Round

2018 Series A

Financing Round: Series A+

Financing Amount:RMB 30 million

Use of Proceeds:Market Expansion, Corporate Operations

Project Valuation:RMB 300 million

Corporate Tags:

Leadless Cardiac Pacemaker

Project Introduction:

Leadless Cardiac Pacemaker: A Novel Device Integrating the Pulse Generator and Pacing Electrode into a Single UnitThe leadless cardiac pacemaker is a novel device that integrates the pulse generator and pacing electrode into a single unit. Implanted via catheter through the femoral vein into the patient’s cardiac chamber in the form of a miniature capsule, it reduces volume and weight to approximately one-tenth that of conventional pacemakers. The leadless cardiac pacemaker represents a revolutionary advancement in the field of cardiac rhythm management.

Cardiac pacemakers constitute a monopolistic industry with high technological barriers, and leadless cardiacPacemaker technology demands higher technical standards, and currently, only one foreign company has such products commercially available worldwide. The domestic market offers substantial growth potential. Dunbo Medical has mastered the core technologies for leadless cardiac pacemakers and is the first Chinese enterprise to undertake R&D in this field. The company has already completed the development and manufacturing of the core chips for its leadless cardiac pacemaker.

Financing History:

Angel Round: RMB 10 million

Financing Round：Pre-Series A

Financing Amount:RMB 40 million

Use of Funds:R&D, Production Line Construction, Equipment Procurement, Animal Testing

Project Valuation:250 million yuan